ValueClick (VCLK) rated new buy at Goldman. $25 price target. Purest play on expected growth in programmatic tier of the display market.
Vertex Pharmaceuticals (VRTX) rated new Outperform at Baird. $53 price target. Cystic Fibrosis franchise can drive growth.
Viasat (VSAT) upgraded at Needham from hold to buy, Needham said. $50 price target. Company is seeing better subscriber growth.Yahoo! (YHOO - Get Report) upgraded at Pivotal from hold to buy, Pivotal Research said. Yahoo Japan continues to grow in value.
STOCK COMMENTS / EPS CHANGESAllergan (AGN) price target increased at Citigroup to $124, Citigroup said. Core franchises continue to deliver double digit growth. Buy rating. Akamai Tech (AKAM) target lowered at Jefferies. Shares of AKAM now seen reaching $48, Oppenheimer said. Weak quarterly report. Outperform rating. Biogen Idec (BIIB) numbers raised at Jefferies. Shares of BIIB now seen reaching $210, Jefferies said. Estimates also raised on acquisition of Tysabri rights. Buy rating. Cummins (CMI) target raised at UBS to $135, UBS said. Opportunity to rally as investors were braced for cautious guidance. Cummins target lowered at Jefferies to $110, Jefferies said. Solid quarter and guidance. Hold rating. CVS Caremark (CVS) numbers increased at Guggenheim. CVS estimates were raised through 2014, Guggenheim said. Company boosted its guidance. Buy rating and new $60 price target. Green Mountain (GMCR) numbers boosted at Lazard. Shares of GMCR now seen reaching $58, according to Lazard Capital Markets. Estimates also upped, given a better margin outlook. W.R. Grace (GRA) numbers raised at Jefferies. Shares of GRA now seen reaching $90, Jefferies said. Estimates also raised on solid earnings momentum. Buy rating. InterActiveCorp (IACI) estimates, target cut at Credit Suisse. Shares of IACI now seen reaching $62, according to Credit Suisse. Estimates also reduced, given a deceleration of search growth. Outperform rating. Panera Bread (PNRA) target raised at Jefferies to $190, Jefferies said. Trends are quite steady vs peers. Buy rating. Ralph Lauren (RL) numbers raised at UBS. Shares of RL now seen reaching $195, UBS said. Estimates also increased on an accelerating top line story. Buy rating. Ralph Lauren numbers raised at Credit Suisse. Shares of RL now seen reaching $198, according to Credit Suisse. Estimates also increased, given higher international growth and margin expansion. Outperform rating. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.